Share chart Cyclacel Pharmaceuticals, Inc.
Extended chart
Simple chart
About Cyclacel Pharmaceuticals, Inc.
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's lead product includes fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and Plogosertib, a polo-like kinase inhibitor program, which is in Phase 1/2 clinical trial for the treatment of advanced leukemias and solid tumors. more details| IPO date | 2005-11-30 |
|---|---|
| ISIN | US23254L2079 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 2.99 |
| Дивиденд ао | 0.6 |
| Сайт | https://www.cyclacel.com |
| Цена ао | 18.2 |
| Change price per day: | 0% (6.47) |
|---|---|
| Change price per week: | +6.94% (6.05) |
| Change price per month: | -4.15% (6.75) |
| Change price per 3 month: | -7.57% (7) |
| Change price per half year: | -31.24% (9.41) |
| Change price per year: | -60.36% (16.32) |
| Change price per 3 year: | -19.13% (8.0001) |
| Change price per 5 year: | +1 152.18% (0.5167) |
| Change price per 10 year: | 0% (6.47) |
| Change price per year to date: | -13.73% (7.5) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Sound Income Strategies, LLC | 182 | 14.46 |
| UBS Group AG | 17 | 1.35 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Spiro George Rombotis | President, CEO & Executive Director | 612.47k | 1959 (66 years) |
| Mr. Paul McBarron | Executive VP of Finance, CFO, COO, Secretary & Executive Director | 321.61k | 1961 (64 years) |
| Ms. Gill Christie | Director of Human Resources | N/A | 1957 (68 years) |
| Dr. Brian Schwartz M.D. | Chief Medical Officer & Director | 53k | 1962 (63 years) |
| Grace Kim | Investor Relations Executive | N/A |
Address: United States, Berkeley Heights. NJ, 200 Connell Drive - open in Google maps, open in Yandex maps
Website: https://www.cyclacel.com
Website: https://www.cyclacel.com
